Kane Biotech (KNE) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free KNE Stock Alerts C$0.14 +0.01 (+3.70%) (As of 09:49 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 7:21 PM | finance.yahoo.comKane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound MapApril 30, 2024 | msn.comHarry Kane on target but Vinicius Jr brace earns Real Madrid first-leg drawApril 28, 2024 | reuters.comKane double steers Bayern 2-1 past Frankfurt ahead of Real clashApril 27, 2024 | msn.comKane sets personal record with double in Bayern winApril 23, 2024 | insidertrades.comKane Biotech Inc. (CVE:KNE) Director Sells C$260,000.00 in StockApril 16, 2024 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 16, 2024 | tmcnet.comKane Biotech to Host Investor WebinarApril 15, 2024 | msn.comDual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares HigherApril 15, 2024 | stockhouse.comKane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsApril 12, 2024 | barrons.com'Light Injuries': Harry Kane's Children In Munich Car AccidentApril 11, 2024 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal HealthApril 11, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - KNEApril 11, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - KNEMarch 29, 2024 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | finance.yahoo.comKane Biotech Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 20, 2024 | finance.yahoo.comKane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal HealthMarch 8, 2024 | tmcnet.comKane Biotech Receives Bioscience Association Manitoba Company of the Year AwardFebruary 24, 2024 | msn.comChicago Blackhawks brace for Patrick Kane’s return — as a Detroit Red Wing: ‘It’s definitely weird’January 31, 2024 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Files New Patent on revyve Antimicrobial Wound Gel SprayJanuary 31, 2024 | financialpost.comKane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel SprayJanuary 31, 2024 | stockhouse.comKane Biotech Files New Patent on revyve(TM) Antimicrobial Wound Gel SprayJanuary 25, 2024 | markets.businessinsider.comKane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care SymposiumJanuary 18, 2024 | finance.yahoo.comKane Biotech Announces Special Meeting of ShareholdersDecember 29, 2023 | finance.yahoo.comKane Biotech Announces Correction to Press ReleaseNovember 29, 2023 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces Improved Third Quarter 2023 Financial ResultsNovember 28, 2023 | finance.yahoo.comKane Biotech Announces Improved Third Quarter 2023 Financial ResultsNovember 2, 2023 | finanznachrichten.deKane Biotech Inc.: Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve Antimicrobial Wound Gel at Advanced Wound Care Fall ForumNovember 2, 2023 | markets.businessinsider.comKane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall ForumNovember 2, 2023 | msn.comHarry Kane’s first ‘Klassiker’ at Bayern overshadowed by de Ligt injury and shock cup exitOctober 25, 2023 | stockhouse.comKane Biotech to Exhibit at Symposium on Advanced Wound Care Fall ForumOctober 17, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc flat on Tuesday (KNE)September 12, 2023 | finance.yahoo.comKane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit FacilityAugust 30, 2023 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces Second Quarter 2023 Financial ResultsAugust 29, 2023 | finance.yahoo.comKane Biotech Announces Second Quarter 2023 Financial ResultsAugust 5, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc down on Thursday (KNE)August 3, 2023 | finance.yahoo.comKane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit FacilityAugust 2, 2023 | finance.yahoo.comKane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal HealthJune 23, 2023 | finance.yahoo.comKane Biotech Announces Issuance of Restricted Share UnitsMay 26, 2023 | finanznachrichten.deKane Biotech Inc.: Kane Biotech Announces First Quarter 2023 Financial ResultsMay 25, 2023 | finance.yahoo.comKane Biotech Announces First Quarter 2023 Financial ResultsMay 25, 2023 | finance.yahoo.comKane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound GelMay 16, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc up on Monday (KNE)May 12, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc down on Friday (KNE)May 11, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc up on Wednesday (KNE)May 6, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc flat on Friday (KNE)May 5, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc up on Thursday (KNE)May 3, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc down on Tuesday (KNE)May 2, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc flat on Monday (KNE)April 27, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc down on Wednesday (KNE)April 22, 2023 | theglobeandmail.comClosing Bell: Kane Biotech Inc up on Friday (KNE) Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. KNE Media Mentions By Week KNE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNE News Sentiment▼1.110.55▲Average Medical News Sentiment KNE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNE Articles This Week▼10▲KNE Articles Average Week Get Kane Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sirona Biochem News Ceapro News Resverlogix News Antibe Therapeutics News Covalon Technologies News Aptose Biosciences News Innovotech News IBEX Technologies News Microbix Biosystems News Small Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:KNE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
